Brain Metastasis Prediction by Transcriptomic Profiling in Triple-Negative Breast Cancer

Area of Science:

• Oncology
• Genomics
• Translational Research

Background:

• Triple-negative breast cancer (TNBC) is aggressive and prone to metastasis, particularly to the brain.
• Identifying biomarkers for brain metastasis (BM) in TNBC is crucial for targeted therapies.
• Current understanding of TNBC biology and metastasis risk requires further investigation.

Purpose of the Study:

• To identify transcriptomic profiles in primary TNBC tumors predictive of brain metastasis (BM).
• To correlate gene expression patterns with the occurrence of symptomatic BM in TNBC patients.
• To inform the development of novel therapeutic and preventive strategies for high-risk TNBC patients.

Main Methods:

• Utilized a cDNA-mediated annealing, selection, extension, and ligation assay to analyze 29,369 gene transcripts.
• Examined primary TNBC tumor samples from 119 patients across two independent cohorts (discovery and validation).
• Correlated messenger RNA (mRNA) expression levels with the incidence of symptomatic BM.

Main Results:

• No significant association was found between primary tumor gene transcripts and BM development in either cohort.
• Initial analysis in the discovery cohort identified potential candidate transcripts, but these did not validate in the independent cohort.
• The study did not identify predictive biomarkers for BM using primary tumor transcriptomics.

Conclusions:

• Primary tumor gene expression alone is insufficient for predicting BM in advanced TNBC.
• The study highlights the complexity of TNBC metastasis and the limitations of current transcriptomic analysis for BM prediction.
• Findings underscore the need for advanced molecular assays and further research into TNBC biology and metastasis.